ArticleInternational journal of pharmaceutics2018

Subcutaneous administration of Lyso-phosphatidylserine nanoparticles induces immunological tolerance towards Factor VIII in a Hemophilia A mouse model.

Fiona Y Glassman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.